FXR agonists

Details for Australian Patent Application No. 2007267606 (hide)

Owner Eli Lilly and Company

Inventors Warshawsky, Alan M.; Ma, Tianwei; Qu, Fucheng; Stites, Ryan Edward; Lander, Peter Ambrose; Ochoada, Jason Matthew; Doti, Robert Anthony; Bell, Michael Gregory; Manninen, Peter Rudolph; Stelzer, Lindsay Scott; Genin, Michael James

Agent Spruson & Ferguson

Pub. Number AU-A-2007267606

PCT Pub. Number WO2007/140183

Priority 60/802,920 24.05.06 US; 60/869,995 14.12.06 US

Filing date 22 May 2007

Wipo publication date 6 December 2007

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/140183 Priority application(s): WO2007/140183

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267612-Preparation and utility of substituted carboxylic acid compounds

2007267593-Macrophage migration inhibitory factor antagonists and methods of using same